Advancing Precision Medicine Drug Development: Incorporation of Real-World Data and Other Novel Strategies
January 9-12, 2020
Westin San Diego Gaslamp Quarter
San Diego, California
Conference Cochairs
David M. Hyman, Memorial Sloan Kettering Cancer Center, New York, New York
Elaine R. Mardis, The Institute for Genomic Medicine at Nationwide Children’s Hospital, Columbus, Ohio
Lillian L. Siu, Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Eliezer M. Van Allen, Dana-Farber Cancer Institute, Boston, Massachusetts
- Watch this video from Conference Cochairs David M. Hyman, Lillian L. Siu, and Eliezer M. Van Allen:
Although the AACR Special Conferences Series has presented more than 200 programs since 1988, this Special Conference will be unique as it is the first program designed to address traditional cancer research topics such as trial design, diagnostics, and drug development; technology topics such as real-time patient monitoring, EHRs, and machine learning; and regulatory and financial considerations in the era of precision medicine.
In order to cover this wide array of topics over the four-day program, the Cochairs have identified a roster of speakers featuring leaders from academia, government, and the biotech, pharma, technology, finance, and insurance sectors, including several individuals who will be new to the AACR. Make plans to join us in San Diego from January 9-12, 2020 for this exciting new program.
Supporters
Lilly Oncology
Professional Educational Grants
AstraZeneca
Celgene
Genentech
Novartis
Pfizer
Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available
